Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers

• Main Authors: Russo, Andrew F, Raddant, Ann C, Recober, Ana, Latham, John A, Smith, Jeffrey T.l, Kovacevich, Brian Robert, Garcia-Martinez, Leon F, Kuburas, Adisa, Kaiser, Eric A
• Format: Patent
• Language: English
• Published: 26.08.2022
• Subjects: CHEMISTRY; HUMAN NECESSITIES; HYGIENE; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES; MEASURING; MEDICAL OR VETERINARY SCIENCE; METALLURGY; ORGANIC CHEMISTRY; PEPTIDES; PHYSICS; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; TESTING

Disclosed is a method of inhibiting photophobia or light aversion or precluding the onset of photophobia or photoaversion in a subject in need thereof comprising administering an effective amount of an anti-CGRP antibody or antibody fragment, anti-CGRP receptor antibody or fragment, or a polypeptide...